Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Risk-stratification of pediatric thyroid nodules using ATA and ACR TIRADS adult thyroid nodule scoring systems.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

The relationship between microscopic margin positivity and disease recurrence in differentiated thyroid cancer.

Surgery·2026
Same author

Mentorship in General Surgery Residency: A Qualitative Study.

The American surgeon·2026
Same author

Patient-Based Decision Making for Opioid Prescriptions After Ambulatory Breast Operation: A Randomized Clinical Trial.

Journal of the American College of Surgeons·2026
Same author

Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association·2026

Related Experiment Video

Updated: May 24, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Electronic Health Record-Based Screening for Primary Aldosteronism in a Large Academic System.

Sang Ngo1, Joshua C Chao2, Jetesh Sahadeo1

  • 1David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|May 22, 2026
PubMed
Summary

Primary aldosteronism (PA) is underdiagnosed in hypertensive patients. Improving screening adherence can enhance detection, treatment, and cardiovascular outcomes for high-risk individuals.

Keywords:
adrenalectomyaldosterone-renin ratiohypertensionhypokalemiaobstructive sleep apneaprimary aldosteronismscreening

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Experiment Videos

Last Updated: May 24, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Health Services Research

Background:

  • Primary aldosteronism (PA) is an underdiagnosed cause of hypertension.
  • Current clinical practice for PA screening is inconsistent with established guidelines for high-risk populations.
  • Systematic evaluation of PA screening and treatment is needed within large healthcare systems.

Purpose of the Study:

  • To evaluate the rates and patterns of PA screening among hypertensive patients meeting guideline-based criteria.
  • To assess the diagnostic yield of PA screening.
  • To examine subsequent treatment strategies and their impact on patient outcomes.

Main Methods:

  • Retrospective cohort study of hypertensive patients (2017-2019) with 5-year follow-up.
  • Inclusion criteria: meeting at least one Endocrine Society PA screening criterion (resistant hypertension, hypokalemia, adrenal mass, OSA).
  • Screening defined by aldosterone-renin ratio (ARR); positivity by ARR ≥20 and aldosterone ≥10 ng/dl.

Main Results:

  • Of 40,865 hypertensive patients, 43.4% met screening criteria, but only 4.1% were screened.
  • Screening rates varied significantly by indication (e.g., 4.7% for resistant hypertension, 26% for adrenal mass).
  • 28.9% of screened patients tested positive; 12% underwent adrenalectomy, 38% received medical treatment, 50% remained untreated. Treated patients showed improved BP, hypokalemia resolution, and fewer antihypertensive medications at 5 years.

Conclusions:

  • PA is significantly underdiagnosed and undertreated in high-risk hypertensive patients.
  • Adherence to guideline-based screening protocols is crucial for improving PA detection and management.
  • Improved screening and timely treatment may positively impact cardiovascular outcomes in PA patients.